Literature DB >> 8508553

How to measure health status in rheumatoid arthritis in non-English speaking patients: validation of a Spanish version of the Health Assessment Questionnaire Disability Index (Spanish HAQ-DI).

M H Cardiel1, M Abello-Banfi, R Ruiz-Mercado, D Alarcon-Segovia.   

Abstract

The HAQ-Disability Index (HAQ-DI) is a useful instrument to measure health status in rheumatoid arthritis (RA) patients. Translation into another language requires a validation process, however. We have translated the HAQ-DI to be used on Spanish-speaking populations. We administered the questionnaire to 97 RA patients during the course of routine medical care. Reliability, measured by a test-retest with a one-month interval, was high (Spearman's rho = 0.89). Convergent and construct validity was obtained for all comparisons (Pearson's r > 0.4). The instrument was sensitive in detecting clinical improvement. We conclude that the Spanish HAQ-DI retains the characteristics of the original index and can be used to assess outcome in Spanish-speaking patients with RA. The procedure described may be used to translate the instrument into other languages either directly from English or from the Spanish version presented here.

Entities:  

Mesh:

Year:  1993        PMID: 8508553

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  43 in total

1.  Pulmonary function test: its correlation with pulmonary high-resolution computed tomography in patients with rheumatoid arthritis.

Authors:  Daza Leonel; Cervantes Lucia; Muñiz A; Hernández Martha-Alicia; Murillo Blanca
Journal:  Rheumatol Int       Date:  2011-04-17       Impact factor: 2.631

2.  Tumor necrosis factor receptor 2 M196R polymorphism in rheumatoid arthritis and osteoarthritis: relationship with sTNFR2 levels and clinical features.

Authors:  Edith Oregón-Romero; Mónica Vázquez-Del Mercado; Rosa Elena Navarro-Hernández; Norma Torres-Carrillo; Gloria Martínez-Bonilla; Iris Estrada-García; Héctor Rangel-Villalobos; José Francisco Muñoz-Valle
Journal:  Rheumatol Int       Date:  2006-07-27       Impact factor: 2.631

3.  Development of a functional scoring system for rheumatoid arthritis patients with cervical myelopathy.

Authors:  A T Casey; J M Bland; H A Crockard
Journal:  Ann Rheum Dis       Date:  1996-12       Impact factor: 19.103

4.  PAI-1 mRNA expression and plasma level in rheumatoid arthritis: relationship with 4G/5G PAI-1 polymorphism.

Authors:  José Francisco Muñoz-Valle; Sandra Luz Ruiz-Quezada; Edith Oregón-Romero; Rosa Elena Navarro-Hernández; Eduardo Castañeda-Saucedo; Ulises De la Cruz-Mosso; Berenice Illades-Aguiar; Marco Antonio Leyva-Vázquez; Natividad Castro-Alarcón; Isela Parra-Rojas
Journal:  Rheumatol Int       Date:  2011-12-27       Impact factor: 2.631

5.  Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.

Authors:  Z Reyes-Castillo; C A Palafox-Sánchez; I Parra-Rojas; G E Martínez-Bonilla; S del Toro-Arreola; M G Ramírez-Dueñas; G Ocampo-Bermudes; José F Muñoz-Valle
Journal:  Clin Exp Immunol       Date:  2015-09-16       Impact factor: 4.330

6.  Current smoking status is associated to a non-ACR 50 response in early rheumatoid arthritis. A cohort study.

Authors:  Jorge Rojas-Serrano; Leticia Lino Pérez; Conrado García García; Francisco Moctezuma; Everardo Álvarez-Hernández; Janitzia Vázquez-Mellado; José Luis Montiel; Rubén Burgos-Vargas
Journal:  Clin Rheumatol       Date:  2011-05-24       Impact factor: 2.980

7.  Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritis.

Authors:  Norma Torres-Carrillo; Nora Magdalena Torres-Carrillo; Gloria Esther Martínez-Bonilla; Mónica Vázquez-Del Mercado; Claudia Azucena Palafox-Sánchez; Edith Oregón-Romero; Ana Guilaisne Bernard-Medina; Héctor Rangel-Villalobos; José Francisco Muñoz-Valle
Journal:  Clin Exp Med       Date:  2009-02-24       Impact factor: 3.984

8.  The -844 G/A PAI-1 polymorphism is associated with mRNA expression in rheumatoid arthritis.

Authors:  Nora Magdalena Torres-Carrillo; Norma Torres-Carrillo; Mónica Vázquez-Del Mercado; Vidal Delgado-Rizo; Edith Oregón-Romero; Isela Parra-Rojas; José Francisco Muñoz-Valle
Journal:  Rheumatol Int       Date:  2007-09-26       Impact factor: 2.631

9.  Psychometric evaluation of a Moroccan version of health assessment questionnaire for use in Moroccan patients with rheumatoid arthritis.

Authors:  Fatima Ezzahra Abourazzak; Karima Benbouazza; Bouchra Amine; Rachid Bahiri; Noufissa Lazrak; Fatiha Bzami; Imane Jroundi; Redouane Abouqal; Francis Guillemin; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2008-06-06       Impact factor: 2.631

10.  The impact of rheumatoid foot on disability in Colombian patients with rheumatoid arthritis.

Authors:  Adriana Rojas-Villarraga; Javier Bayona; Natalia Zuluaga; Santiago Mejia; Maria-Eugenia Hincapie; Juan-Manuel Anaya
Journal:  BMC Musculoskelet Disord       Date:  2009-06-15       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.